Trial Profile
A Randomized, Open-Label, Crossover, Single-Dose Study to Compare Pharmacokinetic Properties and Safety After Administration of HCP1303 Capsule and Co-administration of HGP1201 Tablet, HIP1402 Capsule Under Fed Condition in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Mar 2016
Price :
$35
*
At a glance
- Drugs HGP 1201 (Primary) ; Tadalafil/tamsulosin (Primary) ; Tamsulosin (Primary)
- Indications Benign prostatic hyperplasia; Erectile dysfunction
- Focus Pharmacokinetics
- Sponsors Hanmi Pharmaceutical
- 28 Mar 2016 New trial record